1006899-20-2

Basic information

• Product Name: 5,5-dimethyl-3-(4-(methylsulfonyl)-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione
• Synonyms: 5,5-dimethyl-3-(4-(methylsulfonyl)-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione
• CAS NO: 1006899-20-2
• Molecular Weight: 350.318
• Mol File: 1006899-20-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5,5-dimethyl-3-(4-(methylsulfonyl)-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 5,5-dimethyl-3-(4-(methylsulfonyl)-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione(1006899-20-2)
• EPA Substance Registry System: 5,5-dimethyl-3-(4-(methylsulfonyl)-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione(1006899-20-2)

Safety Data

• Hazardous Substances Data: 1006899-20-2(Hazardous Substances Data)

Upstream product

• 300356-32-5 4-bromo-1-(methylsulfonyl)-2-(trifluoromethyl)benzene 
• 77-71-4 5,5-dimethyl-imidazolidine-2,4-dione 
• 300356-31-4 (4-bromo-2-(trifluoromethyl)phenyl)(methyl)sulfane 
• 393-37-3 5-bromo-2-fluorobenzotrifluoride 
• 1006899-16-6 5,5-dimethyl-3-(4-methylsulfanyl-3-trifluoromethylphenyl)-imidazolidine-2,4-dione 

Relevant articles and documents

NOVEL IMIDAZOLIDINE-2, 4-DIONE DERIVATIVES

A subject of the present application is novel imidazolidine-2, 4-dione derivatives of general formula (I) These products have an anti-proliferative activity. They are particularly useful for treating the pathological states and the diseases linked to an abnormal cell proliferation such as cancers. The invention also relates to the pharmaceutical compositions containing said products and their use for the preparation of a medicament.

Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof

The invention relates to compounds of formula (I) wherein the groups R and R′ A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.